Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
10.36
-0.46 (-4.25%)
At close: Aug 28, 2026, 4:00 PM EDT
10.45
+0.09 (0.87%)
After-hours: Aug 28, 2026, 7:30 PM EDT
Ocular Therapeutix Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Ocular Therapeutix stock has a consensus rating of "Strong Buy" and an average price target of $27.09. The average 1-year stock price forecast is 161.49% higher than the current stock price, while the lowest is $18 (+73.75%) and the highest is $34 (+228.19%).
Price Target: $27.09 (+161.49%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Ocular Therapeutix stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $31 | Buy | Maintains | $31 | +199.23% | Aug 26, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $27 | Buy | Maintains | $27 | +160.62% | Aug 21, 2026 |
| Clear Street | Clear Street | Buy Reiterates $28 | Buy | Reiterates | $28 | +170.27% | Aug 18, 2026 |
| Needham | Needham | Buy Maintains $18 | Buy | Maintains | $18 | +73.75% | Aug 18, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 17, 2026 |
Financial Forecast
Revenue This Year
52.93M
from 51.95M
Increased by 1.88%
Revenue Next Year
102.48M
from 52.93M
Increased by 93.62%
EPS This Year
-1.43
from -1.42
EPS Next Year
-1.45
from -1.43
EPS and Forward PE are based on non-GAAP adjusted numbers.